Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - maribavirum - compresse rivestite con film - maribavirum 200 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350 e 171 talcum e 133 pro compresso obducto corresp. natrium max. 0.105 mg. - cmv infektion - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

difa cooper s.p.a. - altri antivirali - altri antivirali

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ravizza farmaceutici s.p.a. - altri antivirali - altri antivirali

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

medici domus s.p.a. - altri antivirali - altri antivirali

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

farmaceutici lenza s.r.l. - altri antivirali - altri antivirali

Unione Europea - italiano - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - infezioni da hiv - antivirali per uso sistemico - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Unione Europea - italiano - EMA (European Medicines Agency)

viiv healthcare b.v. - fostemsavir trometamol - infezioni da hiv - antivirali per uso sistemico - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Unione Europea - italiano - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - infezioni da hiv - antivirali per uso sistemico - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 e 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 e 5.

Unione Europea - italiano - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirali per uso sistemico - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Unione Europea - italiano - EMA (European Medicines Agency)

roche registration gmbh - baloxavir marboxil - influenza, umano - antivirali per uso sistemico - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.